• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药师干预对社区药房中带状疱疹疫苗接种的影响。

Effect of pharmacist intervention on herpes zoster vaccination in community pharmacies.

机构信息

College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN 38163, USA.

出版信息

J Am Pharm Assoc (2003). 2013 Jan-Feb;53(1):46-53. doi: 10.1331/JAPhA.2013.12019.

DOI:10.1331/JAPhA.2013.12019
PMID:23636155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3648883/
Abstract

OBJECTIVE

To evaluate the effectiveness of community pharmacy-based interventions in increasing vaccination rates for the herpes zoster vaccine.

DESIGN

Prospective intervention study with a pre-post design.

SETTING

Three independent community pharmacies in Tennessee, from December 2007 to June 2008.

PATIENTS

Patients whose pharmacy profiles indicated that they were eligible for the vaccine and patients presenting to receive the vaccine at study sites.

INTERVENTION

Pharmacists promoted the herpes zoster vaccine through a press release published in local newspapers, a flyer accompanying each prescription dispensed at participating pharmacies, and a personalized letter mailed to patients whose pharmacy profiles indicated that they were eligible for the vaccine.

MAIN OUTCOME MEASURES

Comparison of vaccination rates for the herpes zoster vaccine during the control and intervention periods and patients' indication for their sources of education and influence in receiving the vaccine.

RESULTS

Vaccination rates increased from 0.37% (n = 59 of 16,121) during the control period to 1.20% (n = 193 of 16,062) during the intervention period ( P < 0.0001). Cochran-Armitage trend analyses, including the months before and after the interventions, confirmed a significantly higher vaccination rate during the intervention month than other months analyzed. More patients indicated that they were educated about the herpes zoster vaccine by one of the pharmacist-driven interventions than by a physician, family/friend, or other source during the intervention period ( P < 0.0001 for all comparisons). Also, more patients were influenced to receive the vaccination as a result of one of the pharmacist-driven interventions than influenced by a physician ( P = 0.0260) or other source ( P < 0.0001). No difference in the effectiveness of patient influence was found when the pharmacy interventions were compared with family/friends ( P = 0.1025).

CONCLUSION

Three pharmacist-driven interventions were effective in increasing vaccination rates for the herpes zoster vaccine.

摘要

目的

评估基于社区药房的干预措施在提高带状疱疹疫苗接种率方面的效果。

设计

前瞻性干预研究,采用前后设计。

地点

田纳西州的三家独立社区药房,时间为 2007 年 12 月至 2008 年 6 月。

患者

药房档案显示符合接种条件的患者,以及在研究地点接受疫苗接种的患者。

干预措施

药剂师通过在当地报纸上发布新闻稿、在参与药房发放的每份处方上附上传单,以及向药房档案显示符合接种条件的患者邮寄个性化信件,来推广带状疱疹疫苗。

主要观察指标

比较对照组和干预组的带状疱疹疫苗接种率,以及患者接受疫苗接种的教育来源和影响因素。

结果

接种率从对照组的 0.37%(16121 例中的 59 例)上升到干预组的 1.20%(16062 例中的 193 例)(P<0.0001)。包括干预前后几个月的 Cochran-Armitage 趋势分析证实,干预月份的接种率明显高于其他月份。在干预期间,更多的患者表示他们是通过药剂师驱动的干预措施之一而不是医生、家人/朋友或其他来源了解带状疱疹疫苗的,在所有比较中(P<0.0001)。此外,更多的患者因药剂师驱动的干预措施而受到影响而接种疫苗,而不是受到医生(P=0.0260)或其他来源(P<0.0001)的影响。当将药房干预措施与家人/朋友进行比较时,在患者影响的有效性方面没有发现差异(P=0.1025)。

结论

三种药剂师驱动的干预措施有效提高了带状疱疹疫苗的接种率。

相似文献

1
Effect of pharmacist intervention on herpes zoster vaccination in community pharmacies.药师干预对社区药房中带状疱疹疫苗接种的影响。
J Am Pharm Assoc (2003). 2013 Jan-Feb;53(1):46-53. doi: 10.1331/JAPhA.2013.12019.
2
Advocating zoster vaccination in a community pharmacy through use of personal selling.通过个人销售在社区药店倡导带状疱疹疫苗接种。
J Am Pharm Assoc (2003). 2013 Jan-Feb;53(1):70-7. doi: 10.1331/JAPhA.2013.11097.
3
Factors associated with herpes zoster vaccination status and acceptance of vaccine recommendation in community pharmacies.与带状疱疹疫苗接种状况相关的因素以及社区药房中对疫苗推荐的接受程度。
Vaccine. 2014 Sep 29;32(43):5749-54. doi: 10.1016/j.vaccine.2014.08.040. Epub 2014 Aug 27.
4
The Impact of Pharmacist Interventions on Herpes Zoster Vaccination Rates.药剂师干预对带状疱疹疫苗接种率的影响。
Consult Pharm. 2015 Aug;30(8):459-62. doi: 10.4140/TCP.n.2015.459.
5
Retrospective financial analysis of a herpes zoster vaccination program from an independent community pharmacy perspective.从独立社区药房角度对带状疱疹疫苗接种计划进行回顾性财务分析。
J Am Pharm Assoc (2003). 2009 Jan-Feb;49(1):12-7. doi: 10.1331/JAPhA.2009.08030.
6
Assessment of targeted automated messages on herpes zoster immunization numbers in an independent community pharmacy.独立社区药房中关于带状疱疹免疫接种数量的定向自动消息评估。
J Am Pharm Assoc (2003). 2017 May-Jun;57(3S):S293-S297.e1. doi: 10.1016/j.japh.2017.02.007. Epub 2017 Apr 10.
7
Improving herpes zoster vaccination rates through use of a clinical pharmacist and a personal health record.通过临床药师和个人健康记录提高带状疱疹疫苗接种率。
Am J Med. 2013 Sep;126(9):832.e1-6. doi: 10.1016/j.amjmed.2013.02.018. Epub 2013 Jul 3.
8
Improving pneumococcal and herpes zoster vaccination uptake: expanding pharmacist privileges.提高肺炎球菌和带状疱疹疫苗接种率:扩大药剂师权限。
Am J Manag Care. 2013 Sep;19(9):e309-13.
9
Impact of automated telephone messaging on zoster vaccination rates in community pharmacies.自动电话通知对社区药房带状疱疹疫苗接种率的影响。
J Am Pharm Assoc (2003). 2013 Mar-Apr;53(2):182-7. doi: 10.1331/JAPhA.2013.12222.
10
Costs of adult vaccination in medical settings and pharmacies: an observational study.医疗机构和药店成人疫苗接种成本:一项观察性研究。
J Manag Care Spec Pharm. 2014 Sep;20(9):930-6. doi: 10.18553/jmcp.2014.20.9.930.

引用本文的文献

1
Enhancing pharmacist intervention targeting based on patient clustering with unsupervised machine learning.基于无监督机器学习的患者聚类增强药剂师干预靶向性。
Expert Rev Pharmacoecon Outcomes Res. 2025 Feb;25(2):187-195. doi: 10.1080/14737167.2024.2406810. Epub 2024 Sep 23.
2
Promotion and COVID-19 lockdown increase uptake of funded maternal pertussis vaccination in pharmacy: A mixed methods study.促进和 COVID-19 封锁措施增加了药房中受资助的孕妇百日咳疫苗接种率:一项混合方法研究。
PLoS One. 2024 Aug 29;19(8):e0307971. doi: 10.1371/journal.pone.0307971. eCollection 2024.
3
Vaccine promotion strategies in community pharmacy addressing vulnerable populations: a scoping review.社区药房针对弱势群体的疫苗推广策略:范围综述。
BMC Public Health. 2023 Sep 23;23(1):1855. doi: 10.1186/s12889-023-16601-y.
4
Behavioral interventions for vaccination uptake: A systematic review and meta-analysis.接种疫苗行为干预措施:系统评价和荟萃分析。
Health Policy. 2023 Nov;137:104894. doi: 10.1016/j.healthpol.2023.104894. Epub 2023 Sep 4.
5
Outcomes of Pharmacist-Led Pharmaceutical Care Interventions Within Community Pharmacies: Narrative Review.社区药房中由药剂师主导的药学服务干预的结果:叙述性综述
Integr Pharm Res Pract. 2023 May 15;12:113-126. doi: 10.2147/IPRP.S408340. eCollection 2023.
6
Consumer Perceptions of a Shingles Infograph Intervention and Vaccination Plans in Community Pharmacy Settings.消费者对社区药房环境中带状疱疹信息图表干预措施及疫苗接种计划的认知。
Innov Pharm. 2022 Dec 12;13(3). doi: 10.24926/iip.v13i3.4918. eCollection 2022.
7
The impact of pharmacist involvement on immunization uptake and other outcomes: An updated systematic review and meta-analysis.药师参与对免疫接种率和其他结果的影响:更新的系统评价和荟萃分析。
J Am Pharm Assoc (2003). 2022 Sep-Oct;62(5):1499-1513.e16. doi: 10.1016/j.japh.2022.06.008. Epub 2022 Jun 24.
8
Pharmacists' Perceived Barriers to Human Papillomavirus (HPV) Vaccination: A Systematic Literature Review.药剂师对人乳头瘤病毒(HPV)疫苗接种的认知障碍:一项系统文献综述
Vaccines (Basel). 2021 Nov 19;9(11):1360. doi: 10.3390/vaccines9111360.
9
Cabenuva®: Differentiated service delivery and the community Pharmacists' roles in achieving UNAIDS 2030 target in Nigeria.卡贝努瓦(Cabenuva®):差异化服务提供以及社区药剂师在尼日利亚实现2030年联合国艾滋病规划署目标中的作用。
Saudi Pharm J. 2021 Aug;29(8):815-819. doi: 10.1016/j.jsps.2021.06.003. Epub 2021 Jun 15.
10
Delivery of Pharmacogenetic Testing with or without Medication Therapy Management in a Community Pharmacy Setting.在社区药房环境中进行有无药物治疗管理的药物遗传学检测。
Pharmgenomics Pers Med. 2021 Jul 9;14:785-796. doi: 10.2147/PGPM.S314961. eCollection 2021.

本文引用的文献

1
Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.药剂师提供免疫补偿和认可:总结 APhA/AMCP 利益相关者会议的白皮书。
J Am Pharm Assoc (2003). 2011 Nov-Dec;51(6):704-12. doi: 10.1331/JAPhA.2011.11544.
2
Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008.美国 2008 年 60 岁及以上成年人的带状疱疹疫苗接种情况。
Am J Prev Med. 2011 Feb;40(2):e1-6. doi: 10.1016/j.amepre.2010.10.012.
3
Advances in the understanding of the pathogenesis and epidemiology of herpes zoster.带状疱疹发病机制和流行病学研究进展。
J Clin Virol. 2010 May;48 Suppl 1(Suppl 1):S2-7. doi: 10.1016/S1386-6532(10)70002-0.
4
Measuring patient satisfaction in the pharmacy specialty immunization clinic: a pharmacist-run Immunization Clinic at the Veterans Affairs San Diego Healthcare System.衡量药学专业免疫诊所的患者满意度:圣地亚哥退伍军人事务医疗系统中由药剂师运营的免疫诊所。
Int J Pharm Pract. 2010 Apr;18(2):100-7.
5
Pharmacy characteristics, vaccination service characteristics, and service expansion: an analysis of sustainers and new adopters.药房特征、疫苗接种服务特征和服务扩展:维持者和新采用者的分析。
J Am Pharm Assoc (2003). 2010 Jan-Feb;50(1):52-61. doi: 10.1331/JAPhA.2010.09036.
6
Retrospective financial analysis of a herpes zoster vaccination program from an independent community pharmacy perspective.从独立社区药房角度对带状疱疹疫苗接种计划进行回顾性财务分析。
J Am Pharm Assoc (2003). 2009 Jan-Feb;49(1):12-7. doi: 10.1331/JAPhA.2009.08030.
7
Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).带状疱疹的预防:免疫实践咨询委员会(ACIP)的建议。
MMWR Recomm Rep. 2008 Jun 6;57(RR-5):1-30; quiz CE2-4.
8
Pharmacist-managed vaccination program increased influenza vaccination rates in cardiovascular patients enrolled in a secondary prevention lipid clinic.由药剂师管理的疫苗接种项目提高了参加二级预防血脂门诊的心血管疾病患者的流感疫苗接种率。
Pharmacotherapy. 2007 May;27(5):729-33. doi: 10.1592/phco.27.5.729.
9
Pharmacist involvement with immunizations: a decade of professional advancement.药剂师参与免疫接种:十年的专业发展。
J Am Pharm Assoc (2003). 2006 Mar-Apr;46(2):168-79; quiz 179-82. doi: 10.1331/154434506776180621.
10
Statewide impact of pharmacist-delivered adult influenza vaccinations.药剂师提供成人流感疫苗接种的全州范围影响。
Am J Prev Med. 2005 Dec;29(5):450-2. doi: 10.1016/j.amepre.2005.08.003.